DreamCIS

(주)드림씨아이에스 · KOSDAQ · 223250 · Industry: Research and experimental development on medical sciences and pharmacy

Key metrics

Earnings

Revenue, Q3 2026₩17.5bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ-12.5% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY+6.1% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026₩469m As of Sep 30, 2026 Source 1 ↗
Operating income QoQ-79.3% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY-83.2% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩2.0bn As of Nov 19, 2026 Source 1
Buyback decided, last 3 months, % of shares2.7% As of Nov 19, 2026 Source 1, Source 2 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩2.0bn As of Nov 19, 2026 Source 1
Buyback decided, last 12 months, % of shares2.7% As of Nov 19, 2026 Source 1, Source 2 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, last 12 months0 shares As of Nov 19, 2026
Potential new shares, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩0 As of Nov 19, 2026
Supply contracts vs prior-year revenue0.0% As of Nov 19, 2026
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months2 As of Nov 19, 2026
DART filings, previous 3 months5 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)50,375 shares As of Jun 24, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more
Open-market buys, last 12 months (amount)₩259m As of Jun 24, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)50,375 shares As of Jun 24, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more
Insiders who bought, last 12 months5 As of Jun 24, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗, Source 5 ↗ +1 more

Insider transactions (last 12 months)

Open-market buys: 50,375 shares (₩259m). Open-market sells: 0 shares (₩0). Net open-market buying: +50,375 shares. Insiders who bought: 5.

Trade dateInsider (role)TypeSharesPriceAmount
Jun 24, 2026Choi Hwa-seop (Non-registered officer)Open-market buy+5,000 shares₩3,375₩17m
Jun 24, 2026Yang Tae-sik (Non-registered officer)Open-market buy+3,000 shares₩3,569₩11m
May 22, 2026Yoo Jeong-hui (Registered director)Open-market buy+26,400 shares₩5,687₩150m
May 22, 2026Kim Gyeong-sun (Registered director)Open-market buy+1,975 shares₩5,664₩11m
May 22, 2026Jung Jae-seok (Non-registered officer)Open-market buy+2,000 shares₩5,620₩11m
Apr 2, 2026Yoo Jeong-hui (Registered director)Open-market buy+3,000 shares₩4,707₩14m
Apr 1, 2026Yoo Jeong-hui (Registered director)Open-market buy+2,000 shares₩4,898₩10m
Mar 31, 2026Yoo Jeong-hui (Registered director)Open-market buy+7,000 shares₩4,933₩35m
Jan 14, 2026Yoo Jeong-hui (Registered director)Other (Stock option exercise)+60,000 shares——
Jan 14, 2026Jeong Su Yeon (Non-registered officer)Other (Stock option exercise)+16,000 shares——
Jan 14, 2026Baek Yu-jin (Non-registered officer)Other (Stock option exercise)+12,048 shares——
Jan 14, 2026Kim Jeong-a (Non-registered officer)Other (Stock option exercise)+7,968 shares——
Jan 14, 2026I Yong Jeong (Non-registered officer)Other (Stock option exercise)+5,000 shares——
Jan 14, 2026Ju Seon Yeong (Non-registered officer)Other (Stock option exercise)+11,200 shares——

Annual financials

YearRevenueOperating income
2025₩66.6bn₩5.2bn
2024₩58.7bn₩5.1bn
2023₩47.8bn₩1.6bn

Filing timeline